IMP
Process View
cellular response to amino acid stimulus
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to amino acid stimulus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RRAGC | Ras-related GTP binding C | 0.979 | ||
| LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 0.798 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.763 | Mouse | |
| COL1A1 | collagen, type I, alpha 1 | 0.755 | Mouse | |
| LAMTOR2 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 | 0.745 | ||
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.723 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.708 | ||
| TOB1 | transducer of ERBB2, 1 | 0.660 | ||
| UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.474 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.286 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.220 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.209 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.180 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.177 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.160 | ||
| C7orf59 | chromosome 7 open reading frame 59 | 0.158 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.132 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.130 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.116 | ||
| HBXIP | hepatitis B virus x interacting protein | 0.113 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.107 | ||
| LAMTOR3 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 | 0.102 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.101 | Mouse | |
| FBN1 | fibrillin 1 | 0.094 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.083 | Mouse | |
| TFRC | transferrin receptor (p90, CD71) | 0.079 | ||
| DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 0.072 | Mouse | |
| COL6A2 | collagen, type VI, alpha 2 | 0.067 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.057 | Mouse | |
| CTBP1 | C-terminal binding protein 1 | 0.042 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.042 | ||
| UBE2A | ubiquitin-conjugating enzyme E2A (RAD6 homolog) | 0.035 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.033 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.032 | ||
| COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.032 | ||
| NID1 | nidogen 1 | 0.031 | ||
| DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | 0.031 | ||
| EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 0.030 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.030 | ||
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.028 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.027 | Mouse | |
| DAXX | death-domain associated protein | 0.026 | ||
| POSTN | periostin, osteoblast specific factor | 0.025 | ||
| DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.022 | Mouse | |
| JAK2 | Janus kinase 2 | 0.022 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.020 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.020 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.019 | ||
| BGN | biglycan | 0.019 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.018 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.017 | ||
| TCF4 | transcription factor 4 | 0.016 | ||
| RRAGD | Ras-related GTP binding D | 0.016 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.016 | ||
| CAPNS1 | calpain, small subunit 1 | 0.015 | ||
| THBS2 | thrombospondin 2 | 0.015 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.015 | Mouse | |
| CPEB3 | cytoplasmic polyadenylation element binding protein 3 | 0.015 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.015 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.015 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.015 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.014 | ||
| DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0.014 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.013 | ||
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.013 | ||
| THBS1 | thrombospondin 1 | 0.013 | ||
| LAMB1 | laminin, beta 1 | 0.013 | ||
| COL4A5 | collagen, type IV, alpha 5 | 0.012 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.012 | Mouse | |
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.012 | ||
| LAMA4 | laminin, alpha 4 | 0.012 | ||
| LOX | lysyl oxidase | 0.011 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.011 | ||
| THY1 | Thy-1 cell surface antigen | 0.011 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.011 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.011 | ||
| UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.011 | Human | |
| COL11A1 | collagen, type XI, alpha 1 | 0.011 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.010 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.010 |